Schizophrenia Treatments
Find Schizophrenia Treatments
Medications for Schizophrenia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Schizophrenia.
Found 20 Approved Drugs for Schizophrenia
RisperiDONE
Brand Names
Perseris, Risperdal, Risperdal Consta, Risperdal M-TAB, Rykindo, UZEDY
RisperiDONE
Brand Names
Perseris, Risperdal, Risperdal Consta, Risperdal M-TAB, Rykindo, UZEDY
Form: Injection, Tablet, Kit, Solution
Method of administration: Subcutaneous, Oral, Intramuscular
FDA approval date: December 29, 1993
Classification: Atypical Antipsychotic
PERSERIS is indicated for the treatment of schizophrenia in adults. PERSERIS is an atypical antipsychotic indicated for the treatment of schizophrenia in adults. ( 1 )
Clozapine
Brand Names
Clozaril, Versacloz
Clozapine
Brand Names
Clozaril, Versacloz
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: July 08, 1999
Classification: Atypical Antipsychotic
Reduction in the Risk of Recurrent Suicidal Behavior in Schizophrenia or Schizoaffective Disorder CLOZARIL is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for death. The effectiveness of CLOZARIL in reducing the risk of recurrent suicidal behavior was demonstrated over a two-year treatment period in the InterSePT™ trial [see Clinical Studies ( 1. Treatment-Resistant Schizophrenia CLOZARIL is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Because of the risks of severe neutropenia and of seizure associated with its use, CLOZARIL should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see Warnings and Precautions. CLOZARIL is an atypical antipsychotic indicated for: Treatment-resistant schizophrenia. Efficacy was established in an active-controlled study.
ARIPiprazole
Brand Names
Abilify, Abilify Asimtufii, Abilify MAINTENA, Opipza
ARIPiprazole
Brand Names
Abilify, Abilify Asimtufii, Abilify MAINTENA, Opipza
Form: Injection, Tablet, Kit, Film, Solution
Method of administration: Oral, Intramuscular
FDA approval date: November 15, 2002
Classification: Atypical Antipsychotic
ABILIFY (aripiprazole) Tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette's Disorder ABILIFY is an atypical antipsychotic. ABILIFY is indicated for: Schizophrenia ( 1.
Paliperidone
Brand Names
Erzofri, Invega, Invega HAFYERA, Invega SUSTENNA, Invega TRINZA
Paliperidone
Brand Names
Erzofri, Invega, Invega HAFYERA, Invega SUSTENNA, Invega TRINZA
Form: Injection, Tablet
Method of administration: Oral, Intramuscular
FDA approval date: December 19, 2006
Classification: Atypical Antipsychotic
ERZOFRI is indicated for the treatment of: Schizophrenia in adults. Schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants. ERZOFRI is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 ) Treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants. ( 1 )
Showing 1-5 of 20
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances